Wir verwenden Cookies, um für diese Website Funktionen wie z.B. Login, einen Warenkorb oder die Sprachwahl zu ermöglichen und für anonymisierte, statistische Auswertungen der Nutzung. Mehr Informationen finden Sie in unserer Datenschutzerklärung. OK, ich habe verstanden
Quintessence International



Kennwort vergessen?


Quintessence Int 48 (2017), Nr. 5     18. Apr. 2017
Quintessence Int 48 (2017), Nr. 5  (18.04.2017)

Seite 419-429, doi:10.3290/j.qi.a37382, PubMed:27981266, Sprache: Englisch

Initial accuracy assessment of the modified S-LANSS for the detection of neuropathic orofacial pain conditions
Herrero Babiloni, Alberto / Nixdorf, Donald R. / Law, Alan S. / Moana-Filho, Estephan J. / Shueb, Sarah S. / Nguyen, Ruby H. / Durham, Justin
Objective: To evaluate the accuracy of a questionnaire modified for the identification of intraoral pain with neuropathic characteristics in a clinical orofacial pain sample population.
Method and Materials: 136 participants with at least one of four orofacial pain diagnoses (temporomandibular disorders [TMD, n = 41], acute dental pain [ADP, n = 41], trigeminal neuralgia [TN, n = 19], persistent dentoalveolar pain disorder [PDAP, n = 14]) and a group of pain-free controls (n = 21) completed the modified S-LANSS, a previously adapted version of the original questionnaire devised to detected patients suffering from intraoral pain with neuropathic characteristics. Psychometric properties (sensitivity, specificity, positive predictive value [PPV], negative predictive value [NPV]) were calculated in two analyses with two different thresholds: (1) Detection of pain with neuropathic characteristics: PDAP + TN were considered positive, and TMD + ADP + controls were considered negative per gold standard (expert opinion). (2) Detection of PDAP: PDAP was considered positive and TMD + ADP were considered negative per gold standard. For both analyses, target values for adequate sensitivity and specificity were defined as ? 80%.
Results: For detection of orofacial pain with neuropathic characteristics (PDAP + TN), the modified S-LANSS presented with the most optimistic threshold sensitivity of 52% (95% confidence interval [CI], 34-69), specificity of 70% (95% CI, 60-79), PPV of 35% (95% CI, 22-51), and NPV of 82% (95% CI, 72-89). For detection of PDAP only, with the most optimistic threshold sensitivity was 64% (95% CI, 35-87), specificity 63% (95% CI, 52-74), PPV 23% (95% CI, 11-39) and NPV 91% (95% CI, 81-97).
Conclusion: Based on a priori defined criteria, the modified S-LANSS did not show adequate accuracy to detect intraoral pain with neuropathic characteristics in a clinical orofacial pain sample.

Schlagwörter: atypical odontalgia, chronic pain, mass screening, neuralgia, root canal therapy, surveys and questionnaires
Volltext (keine Berechtigung) einzeln als PDF kaufen (20.00 €)